Additional studies, including in subjects from other ethnic groups and with varying degrees of CVD severity, to further define the importance of platelet reactivity in those who carry the at-risk genotype may provide mechanistic insights towards personalized medicine through genotype-specific interventions that target platelet reactivity.AcknowledgmentsThis work was supported by NIH research grant